HawkCell

HawkCell is a Lyon, France-based medtech company that has developed a unique magnetic resonance imaging (MRI) plug-and-play solution specifically designed for veterinary applications. The company's innovative system combines advanced hardware and software components, enabling the transformation of standard human MRI scanners into dedicated animal imaging systems.

At the core of HawkCell's technology are patented 3D-printed MRI coils tailored to the unique morphology of animals, ensuring optimal image quality. Additionally, the system incorporates a proprietary animal positioner that minimizes the need for anesthesia, reducing potential risks. The hardware components are complemented by sophisticated AI algorithms that enhance image quality through denoising and quantitative analysis, while simultaneously accelerating the image acquisition process.

HawkCell's system is manufacturer-agnostic, compatible with any existing human MRI scanner, making it a versatile and cost-effective solution for veterinary clinics and research facilities. The technology offers veterinarians and researchers improved diagnostic capabilities, increased efficiency, and unprecedented precision in animal imaging.

The company's expertise encompasses a wide range of medical domains, including neurology, cardiology, gastrointestinal disorders, musculoskeletal conditions, inflammation, oncology, metabolic diseases, and biocompatibility evaluations. This broad applicability positions HawkCell's solution as a valuable tool for both animal healthcare and preclinical research.

In March 2024, HawkCell successfully raised EUR 5 million in a Series A funding round led by MIG Capital, with participation from a French investment bank. The financing will enable the company to scale its operations, intensify its efforts in advancing animal imaging, and expand into the North American pet market.